Antibiotics Channel
Topics & Medications
Quicklinks
Related Channels
Vibramycin Dosage
Before prescribing a dosage of Vibramycin, your healthcare provider will consider several factors, such as your weight (for children), the medical condition being treated, other medications you are taking, and other medical conditions you may have. Vibramycin comes in the form of capsules and a liquid and is typically taken once or twice a day. The recommended dosing for most types of bacterial infections in adults is 100 mg to 200 mg per day for 7 to 14 days.
The dose of Vibramycin® (doxycycline) your healthcare provider recommends will vary, depending on a number of factors, including:
- The medical condition being treated
- Your weight (for children)
- Other medications you are taking
- Other medical conditions you may have.
As is always the case, do not adjust your dosing unless your healthcare provider specifically instructs you to do so.
The recommended Vibramycin dosage for most types of bacterial infections in adults is 100 mg to 200 mg per day for 7 to 14 days. For chronic (long-term) or more serious infections, longer treatment may be required.
In children ages 8 years old or older, your healthcare provider will prescribe a Vibramycin dosage based on the child's weight, usually about 1 mg to 2 mg per pound of body weight per day. The dose is taken for 7 to 14 days. Children that weigh more than 100 pounds should receive the standard adult dosage. Vibramycin is a good choice for children because it comes in oral suspension (liquid) form.
The recommended dose of Vibramycin for preventing malaria in adults is 100 mg daily. For children, the dosage is 2 mg per kilogram of body weight (about 0.9 mg per pound), not to exceed 100 mg per day. Treatment should begin a day or two prior to travel, taken throughout your stay in the area of concern, and continued for 28 days after you have left the noted area. Usage should not exceed four months.
Written by/reviewed by: Kristi Monson, PharmD; Arthur Schoenstadt, MD
Last reviewed by: Kristi Monson, PharmD



